|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Noncash adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation, amortization and other | |||||
| Impairment of intangible assets | |||||
| Stock-based compensation expense | |||||
| Deferred income taxes | |||||
| Acquired in-process research and development | |||||
| Adjustments for equity method investments | |||||
| Loss on divestiture | |||||
| (Gains) losses on equity securities | |||||
| Other items, net | |||||
| Changes in operating assets and liabilities, net of acquisitions: | |||||
| Trade receivables, net | |||||
| Inventories | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued income taxes, net | |||||
| Long-term tax liabilities | |||||
| Accrued liabilities | |||||
| Accrued sales incentives and allowance | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Cash paid for acquisitions, net of cash acquired | |||||
| Purchases of marketable securities | |||||
| Proceeds from sales of marketable securities | |||||
| Proceeds from maturities of marketable securities | |||||
| Purchases of property, plant and equipment | |||||
| Other | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Net proceeds from issuance of debt | |||||
| Extinguishment of debt | |||||
| Repayment of debt | |||||
| Repurchases of common stock | |||||
| Dividends paid | |||||
| Other | |||||
| Net cash (used in) provided by financing activities | |||||
| (Decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
Loading...